K. Bross

2.5k total citations
62 papers, 1.9k citations indexed

About

K. Bross is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, K. Bross has authored 62 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in K. Bross's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Sarcoidosis and Beryllium Toxicity Research (7 papers). K. Bross is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Sarcoidosis and Beryllium Toxicity Research (7 papers). K. Bross collaborates with scholars based in Germany, United States and Canada. K. Bross's co-authors include Ulrich Costabel, H Matthys, Reinhard Andreesen, W. Krone, Karl G. Blume, Albrecht Reichle, G. W. Löhr, Wayne E. Spruce, Gerassimos A. Pangalis and G. W. Löhr and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

K. Bross

59 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
K. Bross 507 480 410 389 372 62 1.9k
Niels Ebbe Hansen 157 0.3× 422 0.9× 525 1.3× 491 1.3× 302 0.8× 50 1.6k
Makoto Hirokawa 292 0.6× 363 0.8× 983 2.4× 576 1.5× 405 1.1× 121 2.6k
Andrzej Lange 507 1.0× 466 1.0× 1.3k 3.3× 730 1.9× 850 2.3× 164 3.0k
T Törnroth 380 0.7× 547 1.1× 371 0.9× 155 0.4× 95 0.3× 77 1.8k
Michelle Moore 167 0.3× 425 0.9× 647 1.6× 483 1.2× 333 0.9× 54 1.8k
Robert R. Chilcote 310 0.6× 440 0.9× 277 0.7× 522 1.3× 514 1.4× 47 2.4k
Johann Lorenzen 183 0.4× 660 1.4× 410 1.0× 299 0.8× 500 1.3× 75 2.4k
P.J.L. Cook 392 0.8× 673 1.4× 157 0.4× 279 0.7× 248 0.7× 69 2.0k
Thomas M. Ellis 242 0.5× 310 0.6× 1.1k 2.6× 175 0.4× 444 1.2× 66 2.3k
Alain Chevailler 311 0.6× 285 0.6× 841 2.1× 204 0.5× 176 0.5× 87 2.2k

Countries citing papers authored by K. Bross

Since Specialization
Citations

This map shows the geographic impact of K. Bross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Bross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Bross more than expected).

Fields of papers citing papers by K. Bross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Bross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Bross. The network helps show where K. Bross may publish in the future.

Co-authorship network of co-authors of K. Bross

This figure shows the co-authorship network connecting the top 25 collaborators of K. Bross. A scholar is included among the top collaborators of K. Bross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Bross. K. Bross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Costabel, Ulrich, K. Bross, K.-H. Rühle, G. W. Löhr, & H Matthys. (2015). Ia-like Antigens on T-Cells and Their Subpopulations in Pulmonary Sarcoidosis and in Hypersensitivity Pneumonitis. American Review of Respiratory Disease.
2.
Walter, Bernhard, Martin Vogelhuber, Jochen Grassinger, et al.. (2011). Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial. Medical Oncology. 29(2). 799–805. 25 indexed citations
3.
Meidenbauer, Norbert, Gudrun Schlake, K. Bross, & Reinhard Andreesen. (2008). Symptomatische leukämische Infiltration der Lunge als Komplikation einer akuten myeloischen Leukämie. DMW - Deutsche Medizinische Wochenschrift. 123(5). 110–113. 1 indexed citations
4.
Reichle, Albrecht, K. Bross, Thomas Vogt, et al.. (2004). Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far‐advanced melanoma and soft tissue sarcoma. Cancer. 101(10). 2247–2256. 73 indexed citations
5.
Vogt, Thomas, Christian Hafner, K. Bross, et al.. (2003). Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors. Cancer. 98(10). 2251–2256. 116 indexed citations
6.
Hennemann, B., K. Bross, Albrecht Reichle, & Reinhard Andreesen. (1993). Acute alveolitis induced by hydroxyurea in a patient with myeloproliferative syndrome. Annals of Hematology. 67(3). 133–134. 10 indexed citations
7.
Wolff-Vorbeck, Guido, et al.. (1993). In vivo labelling of the spleen with a red-fluorescent cell dye. Journal of Immunological Methods. 165(1). 121–125. 11 indexed citations
8.
Licht, Thomas, et al.. (1992). Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase? in human tumour lines: implications for in vitro chemoresistance. Journal of Cancer Research and Clinical Oncology. 118(2). 116–122. 4 indexed citations
9.
Schiltz, E., et al.. (1992). Unusual Sequence of Immunoglobulin L‐Chain Rearrangements in a Gamma Heavy Chain Disease Patient. Scandinavian Journal of Immunology. 36(3). 463–468. 4 indexed citations
10.
Guzman, Josune, K. Bross, & Ulrich Costabel. (1991). Malignant lymphoma in pleural effusions: An immunocytochemical cell surface analysis. Diagnostic Cytopathology. 7(2). 113–118. 11 indexed citations
11.
12.
Deibert, Peter, et al.. (1991). Demonstration of estrogen and progesterone receptors as well as Ki-67 and p-145 antigens in single tumor cells from blood and pleural effusions using a slide assay. Journal of Cancer Research and Clinical Oncology. 117(3). 217–222. 4 indexed citations
13.
Kanz, Lothar, Wolfram Brugger, K. Bross, & Roland Mertelsmann. (1991). Combination of cytokines: current status and future prospects. British Journal of Haematology. 79(s1). 96–104. 6 indexed citations
14.
Licht, Thomas, Heinz‐Herbert Fiebig, K. Bross, et al.. (1991). Induction of multiple‐drug resistance during anti‐neoplastic chemotherapy in vitro. International Journal of Cancer. 49(4). 630–637. 43 indexed citations
15.
Guzman, Josune, et al.. (1989). Immunocytology in Malignant Pleural Mesothelioma. CHEST Journal. 95(3). 590–595. 17 indexed citations
16.
Guzman, Josune, et al.. (1989). Tuberculous pleural effusions: Lymphocyte phenotypes in comparison with other lymphocyte‐rich effusions. Diagnostic Cytopathology. 5(2). 139–144. 9 indexed citations
17.
Costabel, Ulrich, K. Bross, & H Matthys. (1985). Diagnosis by bronchoalveolar lavage of cause of pulmonary infiltrates in haematological malignancies.. BMJ. 290(6474). 1041–1041. 22 indexed citations
18.
Andreesen, Reinhard, et al.. (1984). Expression of transferrin receptors and intracellular ferritin during terminal differentiation of human monocytes. Annals of Hematology. 49(3). 195–202. 101 indexed citations
19.
Bross, K., et al.. (1984). Immunoglobulin light chains in chronic lymphocytic leukemia and related diseases. Annals of Hematology. 49(4). 339–345. 1 indexed citations
20.
Schmidt, GM, et al.. (1979). The use of lymphocyte phosphoglucomutase as a genetic marker in bone marrow transplant recipients. Annals of Hematology. 38(2). 135–137. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niels Ebbe Hansen Breakdown of academic impact, for papers by Makoto Hirokawa Breakdown of academic impact, for papers by Andrzej Lange Breakdown of academic impact, for papers by T Törnroth Breakdown of academic impact, for papers by Michelle Moore Breakdown of academic impact, for papers by Robert R. Chilcote Breakdown of academic impact, for papers by Johann Lorenzen Breakdown of academic impact, for papers by P.J.L. Cook Breakdown of academic impact, for papers by Thomas M. Ellis Breakdown of academic impact, for papers by Alain Chevailler
Rankless by CCL
2026